Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

Mundt, Arno J; McBride, Russell; Rotmensch, Jacob; Waggoner, Steven E; Yamada, S.Diane; Connell, Philip P

« Previous Next »International Journal of Radiation Oncology * Biology * Physics
Volume 50, Issue 5 , Pages 1145-1153, 1 August 2001

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

Presented at the 42nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), Boston, Massachusetts, October 22–26, 2000.

Arno J Mundt, M.D.
- Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL, USA
- Reprint requests to: Arno J. Mundt, M.D., Department of Radiation and Cellular Oncology, University of Chicago Hospitals, MC 9006, 5758 S. Maryland Ave, Chicago, IL 60637. Tel: (773) 702-4751; Fax: (773) 702-0610
Russell McBride, B.A.
- Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL, USA
Jacob Rotmensch, M.D.
- Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL, USA
- Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Hospitals, Chicago, IL, USA
Steven E Waggoner, M.D.
- Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Hospitals, Chicago, IL, USA
S.Diane Yamada, M.D.
- Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, University of Chicago Hospitals, Chicago, IL, USA
Philip P Connell, M.D.
- Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, IL, USA